Must See: Do You Invest in Midcap Stocks? Here's a Great News for You
Here is the latest financial fact sheet of BALAXI PHARMA. For more details, see the BALAXI PHARMA quarterly results and BALAXI PHARMA share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 1.5 |
No. of shares | m | 11.04 |
1 Week | % | -1.2 |
1 Month | % | 21.7 |
1 Year | % | 5.1 |
52 week H/L | Rs | 686.3/400.0 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
BALAXI PHARMA EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | NA | NA | NA | 702 | 670 | |
Low | Rs | NA | NA | NA | 342 | 490 | |
Sales per share (Unadj.) | Rs | 44.7 | 45.6 | 231.3 | 279.4 | 330.5 | |
Earnings per share (Unadj.) | Rs | 6.5 | 6.1 | 38.1 | 47.7 | 45.2 | |
Diluted earnings per share | Rs | 1.8 | 5.5 | 34.5 | 43.2 | 41.6 | |
Cash flow per share (Unadj.) | Rs | 6.5 | 6.1 | 38.4 | 48.2 | 46.9 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0.50 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.45 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0.1 | 0 | |
Book value per share (Unadj.) | Rs | 11.6 | 27.7 | 65.0 | 113.2 | 169.5 | |
Adj. book value per share | Rs | 3.2 | 25.1 | 58.9 | 102.5 | 156.3 | |
Shares outstanding (eoy) | m | 3.04 | 10.00 | 10.00 | 10.00 | 10.18 | |
Price / Sales ratio | x | 0 | 0 | 0 | 1.9 | 1.8 | |
Avg P/E ratio | x | 0 | 0 | 0 | 10.9 | 12.8 | |
P/CF ratio (eoy) | x | 0 | 0 | 0 | 10.8 | 12.4 | |
Price / Book Value ratio | x | 0 | 0 | 0 | 4.6 | 3.4 | |
Dividend payout | % | 0 | 0 | 0 | 1.0 | 0 | |
Avg Mkt Cap | Rs m | 0 | 0 | 0 | 5,218 | 5,905 | |
Total wages/salary | Rs m | 9 | 21 | 85 | 125 | 290 |
BALAXI PHARMA INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 136 | 456 | 2,313 | 2,794 | 3,364 | |
Other income | Rs m | 9 | 6 | 22 | 50 | 26 | |
Total revenues | Rs m | 145 | 462 | 2,336 | 2,844 | 3,391 | |
Gross profit | Rs m | 16 | 83 | 427 | 508 | 574 | |
Depreciation | Rs m | 0 | 0 | 3 | 5 | 18 | |
Interest | Rs m | 0 | 0 | 3 | 8 | 14 | |
Profit before tax | Rs m | 24 | 88 | 443 | 545 | 569 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 5 | 27 | 62 | 69 | 110 | |
Profit after tax | Rs m | 20 | 61 | 381 | 477 | 460 | |
Gross profit margin | % | 11.5 | 18.1 | 18.4 | 18.2 | 17.1 | |
Effective tax rate | % | 19.4 | 30.6 | 14.0 | 12.6 | 19.3 | |
Net profit margin | % | 14.5 | 13.4 | 16.5 | 17.1 | 13.7 |
BALAXI PHARMA BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 58 | 349 | 938 | 1,410 | 1,935 | |
Current liabilities | Rs m | 26 | 82 | 347 | 633 | 531 | |
Net working cap to sales | % | 23.5 | 58.4 | 25.5 | 27.8 | 41.7 | |
Current ratio | x | 2.2 | 4.2 | 2.7 | 2.2 | 3.6 | |
Inventory Days | Days | 9 | 7 | 5 | 8 | 2 | |
Debtors Days | Days | 146,964 | 2,377 | 1,211 | 360 | 567 | |
Net fixed assets | Rs m | 3 | 11 | 59 | 355 | 462 | |
Share capital | Rs m | 30 | 100 | 100 | 100 | 102 | |
"Free" reserves | Rs m | 5 | 177 | 550 | 1,032 | 1,624 | |
Net worth | Rs m | 35 | 277 | 650 | 1,132 | 1,726 | |
Long term debt | Rs m | 0 | 0 | 0 | 0 | 9 | |
Total assets | Rs m | 61 | 360 | 997 | 1,765 | 2,397 | |
Interest coverage | x | 1,221.0 | 184.2 | 160.5 | 72.6 | 42.3 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 2.2 | 1.3 | 2.3 | 1.6 | 1.4 | |
Return on assets | % | 32.2 | 17.1 | 38.5 | 27.4 | 19.8 | |
Return on equity | % | 55.8 | 22.0 | 58.7 | 42.1 | 26.6 | |
Return on capital | % | 69.3 | 31.9 | 68.6 | 48.9 | 33.6 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 136 | 456 | 869 | 1,000 | 802 | |
Fx outflow | Rs m | 0 | 10 | 110 | 87 | 40 | |
Net fx | Rs m | 136 | 447 | 759 | 913 | 763 |
BALAXI PHARMA CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | -15 | -140 | 0 | 341 | 61 | |
From Investments | Rs m | -0 | -2 | -60 | -284 | -106 | |
From Financial Activity | Rs m | 0 | 181 | 36 | -2 | 255 | |
Net Cashflow | Rs m | -15 | 39 | -23 | 55 | 210 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Ashish Maheshwari | COMP SEC: Nidhin Jose | YEAR OF INC: 1942 | NSE CODE: 911309 | FV (Rs): 10 | DIV YIELD (%): - |
More Trading Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare BALAXI PHARMA With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Indian share markets Slipped further as the session progressed and ended the day weak.